Your browser doesn't support javascript.
loading
Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial.
Stahl, Andreas; Lepore, Domenico; Fielder, Alistair; Fleck, Brian; Reynolds, James D; Chiang, Michael F; Li, Jun; Liew, Melissa; Maier, Rainer; Zhu, Qi; Marlow, Neil.
Afiliação
  • Stahl A; Department of Ophthalmology, University Medical Center, Greifswald, Germany.
  • Lepore D; Department of Ophthalmology, Gemelli Foundation IRCSS, Catholic University of the Sacred Heart, Rome, Italy.
  • Fielder A; Department of Optometry and Visual Science, City, University of London, London, UK.
  • Fleck B; Royal Hospital for Sick Children, University of Edinburgh, Edinburgh, UK.
  • Reynolds JD; Ross Eye Institute, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA.
  • Chiang MF; Casey Eye Institute, Oregon Health & Science University, Portland, OR, USA.
  • Li J; Novartis Pharma, Basel, Switzerland.
  • Liew M; Novartis Pharma, Basel, Switzerland.
  • Maier R; Novartis Pharma, Basel, Switzerland.
  • Zhu Q; China Novartis Institutes for BioMedical Research Company, Shanghai, China.
  • Marlow N; Academic Neonatology, UCL Elizabeth Garrett Anderson Institute for Women's Health, University College London, London, UK. Electronic address: n.marlow@ucl.ac.uk.
Lancet ; 394(10208): 1551-1559, 2019 10 26.
Article em En | MEDLINE | ID: mdl-31522845

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 7_ODS3_muertes_prevenibles_nacidos_ninos Base de dados: MEDLINE Assunto principal: Retinopatia da Prematuridade / Fotocoagulação a Laser / Inibidores da Angiogênese / Ranibizumab Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Newborn Idioma: En Revista: Lancet Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 7_ODS3_muertes_prevenibles_nacidos_ninos Base de dados: MEDLINE Assunto principal: Retinopatia da Prematuridade / Fotocoagulação a Laser / Inibidores da Angiogênese / Ranibizumab Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Newborn Idioma: En Revista: Lancet Ano de publicação: 2019 Tipo de documento: Article